Ushbu ish iqtibos qilgan ishlar

30 ta ish

Ish: Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

1. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

   Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

   Maqola201011 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027992

2. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   Andrew Nunn, Patrick Phillips, Sarah Meredith +16

   Maqola20196 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006848

3. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

   Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

   Maqola20146 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027986

4. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries

   Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe +15

   Maqola20176 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.034213

5. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

   Christopher Kuaban, J Noeske, Hans L. Rieder +3

   Maqola20155 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027995

6. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000054

7. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/openalex/2017.review-article.000004

8. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

   Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies

   Sharh maqola20174 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027999

9. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

   Sharh maqola20184 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.034216

10. Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis

    Maeve K. Lalor, Jane Greig, Sholpan Allamuratova +6

    Maqola20134 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.163894

11. Prediction of Creatinine Clearance from Serum Creatinine

    Donald W. Cockcroft, Henry Gault

    Maqola20083 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.017423

12. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

    J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt +74

    Maqola20153 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.027994

13. WHO recommendations on shorter treatment of multidrug-resistant tuberculosis

    Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +3

    Maqola20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.027996

14. Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations

    Francis Varaine, Lorenzo Guglielmetti, Helena Huerga +5

    Boshqa20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.027998

15. Preferential adherence to antiretroviral therapy over tuberculosis treatment: A qualitative study of drug-resistant TB/HIV co-infected patients in South Africa

    Amrita Daftary, Nesri Padayatchi, Max R. O’Donnell

    Maqola20142 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.184185

16. Research Protocol - Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan

    Philipp du Cros, Khamraev Atadjan, Mirzagalib Tillashaikhov +19

    Maqola20142 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363661

17. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

    Christoph Lange, Raquel Duarte, M. Jachym +7

    Boshqa20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363668

18. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update

    Dennis Falzon, Holger J. Schünemann, Elizabeth Harausz +4

    Maqola20172 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363670

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363662

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363663

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363664

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363665

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363666

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363667

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363669